G&S Capital LLC Biogen Inc. Transaction History

G&S Capital LLC

  • $229 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023
SELL
$275.25 - $318.06 $29,451 - $34,032
-107 Reduced 1.55%
6,800 $1.94 Million
Q1 2023

Apr 20, 2023
BUY
$256.56 - $292.34 $37,970 - $43,266
148 Added 2.19%
6,907 $1.92 Million
Q4 2022

Jan 20, 2023
BUY
$252.44 - $306.72 $1.71 Million - $2.07 Million
6,759 New
6,759 $0

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track G&S Capital LLC Portfolio

Follow G&S Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on G&S Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email